BCLS Fund III Investments, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share (DNTH)

Filing Manager: BCLS Fund III Investments, LP
Reporting Manager: BCLS Fund III Investments, LP
Security: Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: DNTH
Shares outstanding: 30.6M shares
Disclosed Ownership: 2.69M shares
Ownership: 8.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 07:54:51 UTC
Date of event: 31 Dec 2024
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BCLS Fund III Investments, LP	8.8%	2.69M	0	2.69M	/s/ Ricky Sun	Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC